Gene therapy targeting SARM1 blocks pathological axon degeneration in mice
Stefanie Geisler(Washington University in St. Louis), Jeffrey Milbrandt(James S. McDonnell Foundation)
Cited by 154
Related Papers
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
|Science|2004|1.1k
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
|Cell Metabolism|2007|899
The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration
|Neuron|2017|641